BRUKER CORPORATION (BRKR) Operating Margin
- Operating margin · 12 months: Value -0.87%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -0.87% | Operating income / revenue. Period ending 2026-06-30. $-30.60M ÷ $3.50B × 100 ≈ -0.87% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -30.60M USD | Operating Income (Loss) |
| Revenue | 3.50B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 393.50M USD | Research and Development Expense |
| Selling, general and administration | 970.70M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-30.60M | $3.50B | (m) | $393.50M | $970.70M | -0.87% |
| 2026-03-31 | $46.60M | $3.46B | (m) | $399.40M | $963.20M | 1.35% |
| 2025-12-31 | $68.20M | $3.44B | (m) | $395.20M | $946.50M | 1.98% |
| 2025-09-30 | $64.00M | $3.44B | (m) | $400.00M | $946.60M | 1.86% |
| 2025-06-30 | $183.90M | $3.44B | (m) | $399.80M | $934.00M | 5.34% |
| 2025-03-31 | $220.10M | $3.45B | (m) | $391.80M | $923.90M | 6.39% |
| 2024-12-31 | $253.10M | $3.37B | (m) | $376.50M | $893.80M | 7.52% |
| 2024-09-30 | $284.50M | $3.24B | (m) | $355.60M | $857.70M | 8.78% |
| 2024-06-30 | $340.90M | $3.12B | (m) | $328.80M | $805.40M | 10.93% |
| 2024-03-31 | $379.00M | $3.00B | (m) | $307.60M | $762.00M | 12.63% |
| 2023-12-31 | $436.90M | $2.96B | (m) | $294.80M | $729.40M | 14.74% |
| 2023-09-30 | $464.40M | $2.82B | (m) | $274.80M | $682.90M | 16.48% |
| 2023-06-30 | $471.20M | $2.71B | (m) | $259.70M | $650.10M | 17.36% |
| 2023-03-31 | $458.90M | $2.62B | (m) | $248.30M | $624.40M | 17.51% |
| 2022-12-31 | $432.70M | $2.53B | (m) | $235.90M | $607.40M | 17.10% |
| 2022-09-30 | $427.10M | $2.51B | (m) | $230.50M | $596.00M | 17.04% |
| 2022-06-30 | $409.00M | $2.48B | (m) | $226.40M | $592.50M | 16.52% |
| 2022-03-31 | $420.70M | $2.46B | (m) | $222.60M | $575.10M | 17.11% |
| 2021-12-31 | $413.30M | $2.42B | (m) | $220.80M | $561.20M | 17.09% |
| 2021-09-30 | $400.70M | $2.36B | (m) | $219.80M | $538.30M | 16.97% |
| 2021-06-30 | $368.70M | $2.26B | (m) | $216.00M | $511.60M | 16.28% |
| 2021-03-31 | $321.00M | $2.12B | (m) | $204.30M | $479.20M | 15.15% |
| 2020-12-31 | $248.30M | $1.99B | (m) | $198.00M | $468.60M | 12.49% |
| 2020-09-30 | $253.20M | $1.96B | (m) | $187.60M | $468.50M | 12.92% |
| 2020-06-30 | $259.80M | $1.97B | (m) | $185.40M | $479.20M | 13.19% |
| 2020-03-31 | $275.40M | $2.04B | (m) | $189.80M | $501.30M | 13.53% |
| 2019-12-31 | $300.90M | $2.07B | (m) | $187.70M | $500.20M | 14.52% |
| 2019-09-30 | $289.60M | $2.03B | (m) | $185.80M | $487.20M | 14.29% |
| 2019-06-30 | $270.90M | $1.97B | (m) | $181.50M | $468.40M | 13.74% |
| 2019-03-31 | $266.20M | $1.93B | (m) | $176.60M | $454.50M | 13.83% |
| 2018-12-31 | $262.40M | $1.90B | (m) | $173.40M | $444.70M | 13.84% |
| 2018-09-30 | $246.50M | $1.87B | (m) | $172.80M | $440.00M | 13.16% |
| 2018-06-30 | $228.70M | $1.84B | (m) | $171.60M | $436.20M | 12.42% |
| 2018-03-31 | $215.20M | $1.81B | (m) | $168.30M | $428.10M | 11.87% |
| 2017-12-31 | $214.70M | $1.77B | (m) | $162.70M | $415.90M | 12.16% |
| 2017-09-30 | $197.90M | $1.71B | (m) | $157.40M | $403.90M | 11.60% |
| 2017-06-30 | $193.90M | $1.66B | (m) | $154.40M | $397.80M | 11.65% |
| 2017-03-31 | $180.80M | $1.62B | (m) | $150.50M | $395.90M | 11.15% |
| 2016-12-31 | $177.20M | $1.61B | (m) | $149.00M | $390.50M | 11.00% |
| 2016-09-30 | $171.00M | $1.62B | (m) | $147.50M | $393.40M | 10.56% |
| 2016-06-30 | $153.30M | $1.62B | (m) | $143.90M | $392.70M | 9.45% |
| 2016-03-31 | $164.50M | $1.65B | (m) | $144.60M | $390.30M | 10.00% |
| 2015-12-31 | $145.70M | $1.62B | (m) | $145.70M | $392.20M | 8.97% |
| 2015-09-30 | $119.50M | $1.65B | (m) | $150.60M | $407.70M | 7.23% |
| 2015-06-30 | $96.20M | $1.68B | (m) | $158.40M | $419.60M | 5.74% |
| 2015-03-31 | $100.00M | $1.74B | (m) | $165.40M | $436.10M | 5.75% |
| 2014-12-31 | $105.40M | $1.81B | (m) | $174.20M | $451.00M | 5.83% |
| 2014-09-30 | $121.90M | $1.85B | (m) | $181.70M | $450.80M | 6.58% |
| 2014-06-30 | $148.50M | $1.87B | (m) | $185.10M | $448.50M | 7.93% |
| 2014-03-31 | $156.60M | $1.87B | (m) | $187.10M | $440.60M | 8.38% |
| 2013-12-31 | $148.20M | $1.84B | (m) | $190.50M | $437.90M | 8.06% |
| 2013-09-30 | $126.40M | $1.80B | (m) | $191.70M | $445.60M | 7.00% |
| 2013-06-30 | $155.20M | $1.81B | (m) | $191.10M | $441.30M | 8.56% |
| 2013-03-31 | $133.80M | $1.78B | (m) | $196.50M | $444.80M | 7.52% |
| 2012-12-31 | $156.00M | $1.79B | (m) | $195.30M | $442.40M | 8.71% |
| 2012-09-30 | $170.50M | $1.75B | (m) | $189.70M | $434.90M | 9.75% |
| 2012-06-30 | $147.70M | $1.72B | (m) | $188.30M | $434.10M | 8.59% |
| 2012-03-31 | $164.30M | $1.70B | (m) | $180.70M | $421.70M | 9.66% |
| 2011-12-31 | $155.60M | $1.65B | (m) | $177.20M | $406.60M | 9.42% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $155.70M | $1.30B | (m) | $141.40M | $301.10M | 11.93% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $136.70M | $1.11B | (m) | $126.40M | $254.00M | 12.27% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |